Brief: Hungary's Richter acquires women’s health discovery portfolio of U.S.-based Celmatix
03/03/2026 07:03
March 3 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says: ACQUIRES WOMEN’S HEALTH DISCOVERY PORTFOLIO OF US BASED CELMATIX CELMATIX WILL RECEIVE AN UPFRONT PAYMENT AND WILL BE ELIGIBLE TO RECEIVE DEVELOPMENT MILESTONE PAYMENT DEVELOPMENT OF THE ACQUIRED PROGRAMS WILL BE LED BY THE WOMEN'S HEALTH ORIGINAL R&D HUB OF RICHTER IN BELGIUM Source text: [https://www.bse.hu/newkibdata/129409975/Richter_Celmatix_Mar2026_EN.pdf] Further company coverage: GDRB.BU (Reporting by Anita Komuves) ((KOMUVES.Anita@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab